Hydralazine-<wbr/>d<sub>4</sub> (hydro<wbr/>chloride)

Hydralazine-d4 (hydrochloride)

CAT N°: 30765
Price:

724.00 615.40

Hydralazine-d4 is intended for use as an internal standard for the quantification of hydralazine (Item No. 23121) by GC- or LC-MS. Hydralazine is an orally bioavailable vasodilator and antihypertensive agent.{40710} It decreases DNA methylation in Jurkat cells at a concentration of 10 ?M and inhibits extracellular and intracellular production of reactive oxygen species (ROS) in rat macrophages activated by phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) at a concentration of 100 ?M.{40711,40712} Hydralazine (100 ?M) also decreases nitric oxide production and expression of inducible nitric oxide synthase (iNOS) in rat macrophages activated by LPS (Item Nos. 19660 | 19661 | 19662) and interferon-? (IFN-?).{40712} It reduces contraction of rat aortic arterial strips induced by potassium and norepinephrine (Item No. 16673; IC50s = 2.2 and 3.06 mM, respectively).{40713} Hydralazine (2.6 mg/kg) lowers mean arterial blood pressure (MAP) by 41.76% in conscious rats.{40714} Formulations containing hydralazine have been used in the treatment of high blood pressure and heart failure.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View